ClinicalTrials.Veeva

Menu

Assessment of Intracerebral Hematoma

A

Assiut University

Status

Unknown

Conditions

Intracerebral Hematoma

Treatments

Device: transcranial duplex sonography

Study type

Interventional

Funder types

Other

Identifiers

NCT05158660
intracerebral hematoma

Details and patient eligibility

About

The study will assess acute intracerebral hematoma expansion within the first 48 hours from the onset using transcranial duplex sonography in patients who have acute intracerebral hematoma , and will also assess the correlation between the transcranial duplex sonography measurements and the clinical outcome of these patients .

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. first ever non traumatic supratentorial primary intracerebral haemorrhage on non contrast CT brain
  2. admitted within 24 hours of symptom onset

Exclusion criteria

  1. blood diseases, decompansated hepatic or renal impairment, or encephalopathy caused by electrolyte disturbance
  2. on anticoagulant treatment
  3. if devolped major complications during hospitalization ( e.g sever chest infection, hypoxia, or deep venous thrombosis )
  4. comorbid neurological or psychiatric disorders

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

120 participants in 1 patient group

patients assessed by transcranial duplex sonography
Experimental group
Treatment:
Device: transcranial duplex sonography

Trial contacts and locations

0

Loading...

Central trial contact

waleed Gafar

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems